Pandemic (H1N1) 2009 influenza - real threat or unjustified panic? The experience of one pediatric hematology-oncology center

• Autorzy: Ninela Irga , Marcelina Osak , Radoslaw Jaworski , Marek Bronk , Wojciech Kosiak , Elzbieta Adamkiewicz-Drozynska
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

Pandemic (H1N1) 2009 influenza; Children; Oncohematological disorders

• Czasopismo: Open Medicine
• Rocznik: 2012
• Tom: 7
• Numer: 3
• Strony: 296-301

Daty

wydano

2012-06-01

online

2012-03-29

Twórcy

autor

Ninela Irga

• Department of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdansk, Debinki 7, 80-210, Gdansk, Poland,

autor

Marcelina Osak

• Department of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdansk, Debinki 7, 80-210, Gdansk, Poland

autor

Radoslaw Jaworski

• Department of Pediatric Cardiac Surgery, Pomeranian Centre of Traumatology, Nowe Ogrody 1-6, 80-210, Gdansk, Poland

autor

Marek Bronk

• Department of Clinical Microbiology, Clinical Center of Medical University of Gdansk, Debinki 7, 80-210, Gdansk, Poland

autor

Wojciech Kosiak

• Department of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdansk, Debinki 7, 80-210, Gdansk, Poland

autor

Elzbieta Adamkiewicz-Drozynska

• Department of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdansk, Debinki 7, 80-210, Gdansk, Poland

Bibliografia

• [1] Launes C, Rives S, Catala A, Berrueco R, Toll T, Camos M, et al. Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. Br J Haematol 2010; 149:874–878 http://dx.doi.org/10.1111/j.1365-2141.2010.08178.x[Crossref]
• [2] O’Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010; 182:39–44 http://dx.doi.org/10.1503/cmaj.091724[Crossref]
• [3] Wenzel JJ, Panning M, Kaul KL, Mangold KA, Revell PA, Luna RA. Analytical performance determination and clinical validation of the novel Roche RealTime Ready Influenza A/H1N1 Detection Set. J Clin Microbiol 2010; 48:3088–3094 http://dx.doi.org/10.1128/JCM.00785-10[Crossref]
• [4] Flynn P. The handling of the H1N1 pandemic: adoption of the report by the Committee. February 6, 2010. Available at: http://assembly.coe.int/ASP/NewsManager/EMB_NewsManagerView.asp?ID=5633. Accessed February 28, 2011
• [5] Chisholm J, Howe K, Taj M, Zambon M. Influenza immunisation in children with solid tumours. Eur J Cancer 2005; 41:2280–2287 http://dx.doi.org/10.1016/j.ejca.2005.07.006[Crossref]
• [6] Casper C, Englund J, Boeckh M. How I treat influenza in patients with hematologic malignancies. Blood 2010; 115:1331–1342 http://dx.doi.org/10.1182/blood-2009-11-255455[Crossref]
• [7] Guinard A, Grout L, Durand C, Schwoebel V. Outbreak of influenza A(H1N1)v without travel history in a school in the Toulouse district, France, June 2009. Euro Surveill 2009; 14
• [8] Dotis J, Roilides E. H1N1 influenza A infection: an update. Hippokratia 2009; 13:254
• [9] Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872–1879 http://dx.doi.org/10.1001/jama.2009.1496[Crossref]
• [10] Peris A, Zagli G, Barbani F, Tutino L, Biondi S, di-Valvasone S, et al. The value of lung ultrasound monitoring in H1N1 acute respiratory distress syndrome. Anaesthesia 2010; 65:294–297 http://dx.doi.org/10.1111/j.1365-2044.2009.06210.x[Crossref][WoS]
• [11] Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010; 60:257–263 http://dx.doi.org/10.1016/j.jinf.2010.01.009[Crossref]
• [12] Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B, et al. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis 2010; 10:145 http://dx.doi.org/10.1186/1471-2334-10-145[Crossref]
• [13] Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010; 38:e52–e57 http://dx.doi.org/10.1097/CCM.0b013e3181c85d5f[WoS][Crossref]
• [14] Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39:1300–1306 http://dx.doi.org/10.1086/425004[Crossref]
• [15] WHO. Antiviral use and the risk of drug resistance; Pandemic (H1N1) 2009 briefing note 12. September 25, 2009. Available at: http://www.who.int/csr/disease/swineflu/notes/h1n1_antivi-ral_use_20090925/en/. Accessed February 28, 2011
• [16] Metan G, Bozkurt I, Agkus C, Coskun R, Alp E, Sungur M, et al. Hospitalized pandemic influenza A (H1N1) patients in a university hospital. Cent Eur J Med 2010; 6:83–88 http://dx.doi.org/10.2478/s11536-010-0040-7[Crossref][WoS]
• [17] Seiter K, Nadelman RB, Liu D, Ahmed T, Montecalvo MA. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol 2010; 28:e27–e29 http://dx.doi.org/10.1200/JCO.2009.25.8889[Crossref]

Identyfikatory

DOI

10.2478/s11536-011-0165-3